Merck is financing a $1.85 million study being conducted at Texas Tech University to see if lower dosages of its lucrative but controversial cattle growth drug Zilmax could allow the company to reintroduce the product to U.S. and global markets and kick-start sales.
This week, China joined a growing list of countries banning the import of U.S. poultry products following reports of the discovery of a highly contagious strain of avian influenza in three West Coast states.
The Chinese Ministry of Agriculture and the General Administration for Quality Supervision, Inspection and Quarantine issued the ban effective Jan. 9, the USDA said. The move comes in the wake of the December discovery of a highly pathogenic strain of H5N8 in a backyard flock of guinea hens and chickens in Oregon. Separately, the strain was found in wild birds in California and Washington.
The folks at generic pet med maker Putney had plenty to be thankful for this holiday season. The 8-year-old company, which is based in Portland, ME, scored four FDA approvals in the last three months of the year. It ended 2014 with one of its biggest victories to date: the FDA approval of carprofen chewable tablets, a generic version of Zoetis' top-selling Rimadyl pain medication for pets.
POPULAR COMMENT THREADS
Last fall, the Johns Hopkins Hospital in Maryland opened a new medical-imaging center that provides the latest advances in MRI scanning and other services. What's unusual about the center, however, is not so much the technology but rather the mix of clientele.
A survey of 2,000 pet owners conducted by Bayer HealthCare Animal Health and the Companion Animal Parasite Council has revealed that when veterinarians provide information to clients about parasites prevalent in their area, they can drive up clinic visits.
Harvard University engineer David Mooney believes there may be a link between immunotherapy and sterilization. He recently received a $700,000 grant to develop a contraceptive vaccine for pets.
The U.S. Meat Animal Research Center aims to invent livestock that will improve the meat industry's efficiency by producing more offspring at lower costs. But reaching that goal comes at a great cost to the animals' health, according to a heartbreaking story in The New York Times.
PetMed Express announced Tuesday that sales in its third fiscal quarter, ended Dec. 31, fell 1.6% to $49.3 million from the same period a year ago, while net income rose 5.6% to $4.8 million, or 24 cents per share. The Florida-based company, known to consumers as 1-800-PetMeds, declared a quarterly dividend of 17 cents.
From Our Sister Sites
Pfizer got a federal judge to toss an investor lawsuit last year tied its now-withdrawn pain drug Bextra. But it wasn't the only investor suit raising similar issues, namely that the board had not been forthright about issues with the drugs. Another was just days away from trial, that is until the drugmaker agreed to settle it for $400 million.
Investors sent Royal Philips down 5% after it disclosed its 2014 earnings report. Analysts on the call clearly remained unconvinced that the $1.2 billion acquisition of catheter-based imaging company Volcano announced in mid-December would help the company. It's in the midst of making the transition to being solely focused on HealthTech, a combination of healthcare and consumer businesses.